HomeGRF • VIE
add
Grifols SA Class A
Nakaraang pagsara
€10.74
Sakop ng araw
€9.41 - €9.81
Sakop ng taon
€6.58 - €15.51
Market cap
6.24B EUR
Average na Volume
4.00
P/E ratio
46.83
Dividend yield
-
Primary exchange
BME
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.79B | 12.24% |
Gastos sa pagpapatakbo | 376.78M | -3.08% |
Net na kita | 51.69M | -13.19% |
Net profit margin | 2.88 | -22.79% |
Kita sa bawat share | — | — |
EBITDA | 468.09M | 33.73% |
Aktuwal na % ng binabayarang buwis | 31.35% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 806.74M | 66.60% |
Kabuuang asset | 20.28B | -8.07% |
Kabuuang sagutin | 12.29B | -8.95% |
Kabuuang equity | 8.00B | — |
Natitirang share | 679.63M | — |
Presyo para makapag-book | 1.36 | — |
Return on assets | 4.22% | — |
Return on capital | 4.78% | — |
Cash Flow
Net change in cash
| (EUR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 51.69M | -13.19% |
Cash mula sa mga operasyon | 299.61M | 92.51% |
Cash mula sa pag-invest | -196.40M | -59.83% |
Cash mula sa financing | -1.56B | -1,860.81% |
Net change in cash | -1.47B | -3,652.69% |
Malayang cash flow | 243.60M | 627.76% |
Tungkol
Grifols, S.A. is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma–based products, a field in which it is the European leader and largest worldwide, the company also supplies devices, instruments, and reagents for clinical testing laboratories. Wikipedia
Itinatag
Nob 18, 1940
Website
Mga Empleyado
23,000
